Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.71 |
| ▸ | TOP1 | P11387 | 4/20 | 0.68 |
| ▸ | CYCS | P99999 | 4/20 | 0.67 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | TERT | O14746 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RHEB | Q15382 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29583274 | 1.00 | ABCG2 (0.71) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL28463987 | 0.99 | ABCG2 (0.70) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL30872331 | 0.99 | ABCG2 (0.70) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL28491269 | 0.99 | ABCG2 (0.70) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL28498163 | 0.99 | ABCG2 (0.70) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL28131499 | 0.99 | ABCG2 (0.70) | ABCG2TOP1CYCSENPP2TERT | |
| Hydrochloric Acid SCHEMBL28130818 | 0.97 | ABCG2 (0.68) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL28130817 | 0.96 | ABCG2 (0.67) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL25046485 | 0.95 | TOP1 (0.66) | ABCG2TOP1CYCSENPP2TERT | |
| SCHEMBL30925006 | 0.95 | TOP1 (0.66) | ABCG2TOP1CYCSENPP2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | claimed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | claimed |
| US-20180259693-A1 | PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC | FRONTIER SCIENTIFIC, INC. (US) | 2018-09-13 | — | — | US | claimed |
| US-20170235034-A1 | PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC | FRONTIER SCIENTIFIC, INC. (US) | 2017-08-17 | — | — | US | claimed |
| CN-106432366-A | Preparation and application of nano metal-organic framework material PCN-223 based on porphyrin ligand | 哈尔滨理工大学 | 2017-02-22 | — | — | CN | claimed |
| EP-1353925-A2 | PROCESSES FOR LARGE SCALE PRODUCTION OF TETRAPYRROLES | Miravant Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | claimed |
| WO-2002083686-A2 | PROCESSES FOR LARGE SCALE PRODUCTION OF TETRAPYRROLES | MIRAVANT PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | WO | claimed |
| US-6462192-B2 | SUCH AS MESO-FORMYL PORPHYRINS, MESO-ACRYLATE PORPHYRINS, PURPURINS AND BENZOCHLORINS. IN PARTICULAR, TIN ETHYL ETIOPURPURIN (SNET2) AND THE INTERMEDIATES NECESSARY FOR ITS PRODUCTION WITHOUT CHROMATOGRAPHY | MIRAVANT PHARMACEUTICALS, INC. | 2002-10-08 | — | — | US | claimed |
| US-20020137924-A1 | Processes for large scale production of tetrapyrroles | MIRAVANT PHARMACEUTICALS, INC. | 2002-09-26 | — | — | US | claimed |
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | disclosed |
| US-20230302144-A1 | Porphyrin Compounds and Compositions Useful for Treating Cancer | ONCOSELECT THERAPEUTICS, LLC (US) | 2023-09-28 | — | — | US | disclosed |
| US-11590233-B2 | Porphyrin compounds and compositions useful for treating cancer | ONCOSELECT THERAPEUTICS, LLC (US) | 2023-02-28 | — | — | US | disclosed |
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2023-02-16 | — | — | US | disclosed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | disclosed |
| WO-2007047582-A2 | PORPHYRIN COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-04-26 | — | — | WO | disclosed |
| US-20040076585-A1 | Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers | GONG XIANCHANG (US) | 2004-04-22 | — | — | US | disclosed |
| EP-1353925-A2 | PROCESSES FOR LARGE SCALE PRODUCTION OF TETRAPYRROLES | Miravant Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | disclosed |
| WO-2002083686-A2 | PROCESSES FOR LARGE SCALE PRODUCTION OF TETRAPYRROLES | MIRAVANT PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | WO | disclosed |
| US-6462192-B2 | SUCH AS MESO-FORMYL PORPHYRINS, MESO-ACRYLATE PORPHYRINS, PURPURINS AND BENZOCHLORINS. IN PARTICULAR, TIN ETHYL ETIOPURPURIN (SNET2) AND THE INTERMEDIATES NECESSARY FOR ITS PRODUCTION WITHOUT CHROMATOGRAPHY | MIRAVANT PHARMACEUTICALS, INC. | 2002-10-08 | — | — | US | disclosed |
| US-20020137924-A1 | Processes for large scale production of tetrapyrroles | MIRAVANT PHARMACEUTICALS, INC. | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | PPOX, HMBS, PNPO | ABCG2 1887/4885TOP1 2957/4885CYCS 297/4885 |
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | TPO, PPOX, THPO | ABCG2 2368/4885TOP1 446/4885CYCS 282/4885 |
| US-20230302144-A1 | Porphyrin Compounds and Compositions Useful for Treating Cancer | KIT, HCCS, PPIF | ABCG2 559/4885TOP1 176/4885CYCS 256/4885 |
| US-11590233-B2 | Porphyrin compounds and compositions useful for treating cancer | KIT, HCCS, PPIF | ABCG2 559/4885TOP1 176/4885CYCS 256/4885 |
| US-20020137924-A1 | Processes for large scale production of tetrapyrroles | SNU13, NPEPPS, ESYT2 | ABCG2 1070/4885TOP1 2944/4885CYCS 3508/4885 |
| US-20040076585-A1 | Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers | CCDC6, CCDC47, ABCB1 | ABCG2 1644/4885TOP1 298/4885CYCS 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.